229 related articles for article (PubMed ID: 16337960)
1. Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts.
Der P; Cui J; Das DK
J Mol Cell Cardiol; 2006 Feb; 40(2):313-20. PubMed ID: 16337960
[TBL] [Abstract][Full Text] [Related]
2. Generation of survival signal by differential interaction of p38MAPKalpha and p38MAPKbeta with caveolin-1 and caveolin-3 in the adapted heart.
Das M; Cui J; Das DK
J Mol Cell Cardiol; 2007 Jan; 42(1):206-13. PubMed ID: 17069850
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
4. Role of ceramide in ischemic preconditioning.
Cui J; Engelman RM; Maulik N; Das DK
J Am Coll Surg; 2004 May; 198(5):770-7. PubMed ID: 15110811
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide signaling in ischemic heart.
Maulik N; Engelman DT; Watanabe M; Engelman RM; Maulik G; Cordis GA; Das DK
Cardiovasc Res; 1995 Oct; 30(4):593-601. PubMed ID: 8575007
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of specific ceramides in ischemic/reperfused rat heart; effect of ischemic preconditioning.
Beresewicz A; Dobrzyń A; Górski J
J Physiol Pharmacol; 2002 Sep; 53(3):371-82. PubMed ID: 12369735
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide down-regulates caveolin-1 expression in rat brains during focal cerebral ischemia and reperfusion injury.
Shen J; Ma S; Chan P; Lee W; Fung PC; Cheung RT; Tong Y; Liu KJ
J Neurochem; 2006 Feb; 96(4):1078-89. PubMed ID: 16417587
[TBL] [Abstract][Full Text] [Related]
8. Role of myocardial nitric oxide in diabetic ischemia-reperfusion dysfunction: studies in mice with myocyte-specific overexpression of endothelial nitric-oxide synthase.
Pozo-Navas B; Stessel H; Wölkart G; Brunner F
J Pharmacol Exp Ther; 2006 Nov; 319(2):729-38. PubMed ID: 16857730
[TBL] [Abstract][Full Text] [Related]
9. Increased resistance to myocardial ischemia in the Brown Norway vs. Dahl S rat: role of nitric oxide synthase and Hsp90.
Shi Y; Hutchins W; Ogawa H; Chang CC; Pritchard KA; Zhang C; Khampang P; Lazar J; Jacob HJ; Rafiee P; Baker JE
J Mol Cell Cardiol; 2005 Apr; 38(4):625-35. PubMed ID: 15808839
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide during early phase myocardial ischemic preconditioning in rats.
Han HG; Wang ZW; Zhang NB; Zhu HY
Chin Med J (Engl); 2008 Jul; 121(13):1210-4. PubMed ID: 18710640
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection.
Lecour S; Smith RM; Woodward B; Opie LH; Rochette L; Sack MN
J Mol Cell Cardiol; 2002 May; 34(5):509-18. PubMed ID: 12056855
[TBL] [Abstract][Full Text] [Related]
12. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase.
Li G; Labruto F; Sirsjö A; Chen F; Vaage J; Valen G
Eur J Cardiothorac Surg; 2004 Nov; 26(5):968-73. PubMed ID: 15519191
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
Wang XD; Wang ZM; Jia DL; Yu P
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1789-91. PubMed ID: 17919391
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
Serejo FC; Rodrigues LF; da Silva Tavares KC; de Carvalho AC; Nascimento JH
J Cardiovasc Pharmacol; 2007 Apr; 49(4):214-20. PubMed ID: 17438406
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide pathway after long-term cold storage and reperfusion in a heterotopic rat heart transplantation model.
Desrois M; Caus T; Belles PM; Dalmasso C; Lan C; Cozzone PJ; Bernard M
Transplant Proc; 2005 Dec; 37(10):4553-5. PubMed ID: 16387168
[TBL] [Abstract][Full Text] [Related]
16. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury.
Vessey DA; Kelley M; Li L; Huang Y; Zhou HZ; Zhu BQ; Karliner JS
Med Sci Monit; 2006 Oct; 12(10):BR318-24. PubMed ID: 17006394
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.
Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q
Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088
[TBL] [Abstract][Full Text] [Related]
18. Role of polyamines in myocardial ischemia/reperfusion injury and their interactions with nitric oxide.
Zhao YJ; Xu CQ; Zhang WH; Zhang L; Bian SL; Huang Q; Sun HL; Li QF; Zhang YQ; Tian Y; Wang R; Yang BF; Li WM
Eur J Pharmacol; 2007 May; 562(3):236-46. PubMed ID: 17382924
[TBL] [Abstract][Full Text] [Related]
19. Sphingomyelinase causes endothelium-dependent vasorelaxation through endothelial nitric oxide production without cytosolic Ca(2+) elevation.
Mogami K; Kishi H; Kobayashi S
FEBS Lett; 2005 Jan; 579(2):393-7. PubMed ID: 15642349
[TBL] [Abstract][Full Text] [Related]
20. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/reperfusion injury.
Jin ZQ; Zhang J; Huang Y; Hoover HE; Vessey DA; Karliner JS
Cardiovasc Res; 2007 Oct; 76(1):41-50. PubMed ID: 17610857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
